Hamlet BioPharma Stock

Hamlet BioPharma EBIT per Employee

The EBIT per Employee of Hamlet BioPharma (HAMLET B.SL) as of Aug 8, 2026 is -6.89 M SEK. In the previous year, EBIT per Employee was -5.32 M SEK — a change of 29.60% (lower).

EBIT per Employee

-6.89 MSEK

YoY

29.60%

Last updated:

EBIT per Employee of Hamlet BioPharma is 2026 -6.89 M SEK. EBIT per Employee of Hamlet BioPharma was 2025 -5.32 M SEK. It decreases by 29.60% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Hamlet BioPharma Stock analysis

What does Hamlet BioPharma do? Hamlet BioPharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hamlet BioPharma stock

EBIT per Employee of Hamlet BioPharma is -6.89 M SEK in 2026.

EBIT per Employee of Hamlet BioPharma changed from -5.32 M SEK to -6.89 M SEK, representing a 29.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Hamlet BioPharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Hamlet BioPharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Hamlet BioPharma

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Hamlet BioPharma